ࡱ> ilfgh"bjbjF)F)"4$Cg$Cg(""e"""""###ddddddd$jg j:du#####d"">e```# ""d`#d``:cHc"`;:&BCgcdTe0ec.Zj`"Zjcc&Zjc##`#####dd`"###e####Zj#########"m :">40B>: 4 4> B5=45@=>W 4>:C<5=B0FVW $ &/   % "%', /! " ,! % " !"  " #: :>4 33690000-3 V:0@AL:V 70A>18 @V7=V 73V4=>  021:2015 (01>@0B>@=V @50:B828: $ - ;0B5:A-B5AB; "'-B5AB @V4:89 (100 287=); ;07<0-:>=B@>;L ;>B , 4 ?0@0<5B@8; PoG8==8: DIL-E (20 JI); Po7G8= ;V7CNG89 LYE-I (500 MJI); Boule >=B@>;L-8D. >@<0;L=89 4,5 <;; 01V@ @5035=BV2 (0;V1@0=B A, 0;V1@0=B B); >7G8= 4;O ?@><820==O (0:B820FV9=89); >7G8= 4;O ?@><820==O (45?@>B5W=V7CNG89)); 01V@ @5035=BV2 4;O  (RPR 01); !<C6:8 V=48:0B>@=V ;N:>B5AB !100; 03=V9 !?; W210 "5AB-A8AB5<0 Finecare 4;O :V;L:VA=>W 5:A?@5A 4V03=>AB8:8 ?@>:0;LF8B>=V=C; W207 "5AB-A8AB5<0 Finecare 4;O :V;L:VA=>W 5:A?@5A 4V03=>AB8:8 ;V:>20=>3> 35<>3;>1V=C; W269 "5AB-A8AB5<0 Finecare 4;O :V;L:VA=>W 5:A?@5A 4V03=>AB8:8 $5@8B8=C; @525:0;  V>EV<VO (N4AL:0) (12x5 <;); @525:0; - >03C;OFVO (12E1 <;); 010@2;5==O 70 @0<><-=01V@ 4;O 48D5@5=FV0;L=>3> 7010@2;5==O, 4>A;V465==O AB@C:BC@8 :;VB8==>W ABV=:8 V 28O2;5==O ?@8=0;56=>ABV 10:B5@V9 4> 3@0<?>78B82=8E 01> 4> 3@0<=530B82=8E 3@C? 7 :0@1>;>28< @>7G8=>< DC:A8=0 &V;O (REF  030.01 )(75 <;/ 500 <0:A. 287); "5AB-@5035=B Anti-Salmonella I ( - +Vi) 1<;; "5AB-@5035=B Anti-Shigella I (S. flexneri, B8? 1 4> 6, 3@C?0 3,4(y), 6 V 7,8(x) 0 B0:>6 S. sonnei S- V F-D>@<8) 1<;; ;07<0 :@>;OG0 F8B@0B=0 ACE0, 10 0<?C; ?> 1 <;; 8A:8 SD204 Azithromycin / 78B@><VF8= 15 <:3; 8A:8 SD035 Amikacin/<V:0F8= 30 <:3.; 8A:8 SD002 Ampicillin/<?VF8;V= 10 <:3.; 8A:8 SD045 Vancomycin/0=:><VF8= 30 <:3.; 8A:8 SD016 Gentamicin / 5=B0<VF8= 10 <:3.; 8A:8 SD012 Doxycycline Hydrochloride / >:A8F8:;V= 30 <:3.; 8A:8 SD013 Erythromycin 15 mcg / @8B@><VF8= 15 <:3.; 8A:8 SD276 Itraconazole / B@0:>=07>; 30 <:3.; 8A:8 SD224 Ketoconazole/5B>:>=07>; 10 <:3.; 8A:8 SD051 Clindamycin / ;V=40<VF8= 2 <:3.; 8A:8 SD115 Clotrimazole / ;>B@8<07>; 10 <:3.; 8A:8 SD010 Co-Trimoxazole25 mcg (Trimethoprim/Sulphamethoxazole) (1.25/23.75 mcg) / >-B@8<>:A07>; 25 <:3 ("@8<5B>?@8</!C;LD0<5B>:A07>; 25 <:3 1.25/23).; 8A:8 SD272 Miconazole/V:>=07>; 50 <:3.; 8A:8 SD025 Nystatin NS 100 Units/VAB0B8= 100 >48=8FL.; 8A:8 SD023 Nitrofurantoin / VB@>DC@0=B>W= 300 <:3.; 8A:8 SD057 Norfloxacin/>@D;>:A0F8= 10 <:3.; 8A:8 SD088 Oxacillin/:A0F8;V= 1 <:3.; 8A:8 SD028 Penicillin-G P 10 / 5=VF8;V= (5=78;?5=VF8;V=) 10 >48=8FL.; 8A:8 SD030 Rifampicin / VD0<?VF8= 5 <:3. 100 48A:V2 C D;0:>=V.; 8A:8 SD031 Streptomycin / !B@5?B><VF8= 10 <:3.; 8A:8 SD154 Tobramycin (">1@0<VF8=); 8A:8 SD114 Fluconazole/$;N:>=07>; 10 <:3.; 8A:8 SD006 Chloramphenicol / %;>@0<D5=V:>; 30 <:3.; 8A:8 SD047 Cefazolin/&5D07>;V= 30 <:3.; 8A:8 SD219 Cefepime / &5D5?V< 30 <:3.; 8A:8 SD203 Cefoperazone/Sulbactam / &5D>?5@07>=/!C;L10:B0< 75/30 <:3 (!C;L?5@07>=).; 8A:8 SD040 Cephotaxime / &5D>B0:A8< 30 <:3.; 8A:8 SD062 Ceftazidime / &5DB07848< 30 <:3.; 8A:8 SD065 Ceftriaxone / &5DB@V0:A>= 30 <:3. 100 48A:V2 C D;0:>=V.; 8A:8 SD061 Cefuroxime / &5DC@>:A8< 30 <:3. 100 48A:V2 C D;0:>=V.; 8A:8 SD060 Ciprofloxacin / &8?@>D;>:A0F8= 5 <:3.; =B8 A8@>20B:0 E. coli I ?>;V20;5=B=0, 1 <; (O25:K11,O26:K60,O44:K7 4,O55:K59,O78:K80,O111: K58,O114:K-,O119:K69); 5@>?5=5< ( ) 10<:3, !100, 48A:8; V=:><VF8= () 15<:3, !100, 48A:8; ;0@8B@><VF8=>< ( ) 15<:3, !100, 48A:8; 52>D;>:A0F8= ($) 5<:3, !100, 48A:8; 78B@><VF8= (") 15<:3, !100 , 48A:8; <>:A8F8;V=/:;02C;0=>20 :8A;>B0 (<>:A8:;02)  20/10<:3,!100) "01;8FO 1  A:;04V ?@>?>78FVW CG0A=8: ?>28=5= =040B8: 1. #G0A=8: 2:;NG0T 2 FV=C B>20@C: B@0=A?>@BC20==O B>20@C, =020=B065==O, @>720=B065==O B>20@C 7 70=5A5==O< =0 A:;04 0<>2=8:0 (=040B8 30@0=BV9=89 ;8AB). 2. #?0:>2:0, C O:V9 1C45 ?>AB0G0B8AO B>20@ <0T 2V4?>2V40B8 BV9, I> 70@5TAB@>20=0 2 #:@0W=V C 2AB0=>2;5=><C ?>@O4:C, 0 C<>28 715@V30==O ?V4 G0A B@0=A?>@BC20==O <0NBL 1CB8 70157?5G5=V ?>AB0G0;L=8:>< 73V4=> V=AB@C:FVW I>4> 70AB>AC20==O (=040B8 30@0=BV9=89 ;8AB). 3. >AB0G0;L=8: ?>AB02;OT B>20@ 73V4=> 70O2:8 0<>2=8:0 ?@>BO3>< 5-8 @01>G8E 4=V2 7 <><5=BC =04E>465==O 70O2:8 2V4 0<>2=8:0 (=040B8 30@0=BV9=89 ;8AB). !  024:2023">20@V;L:VABL48=8FV 28<V@C"155112 - 52<0B>W4=89 G8==8: IVD (4V03=>AB8:0 in vitro ), =01V@, @50:FVO 03;NB8=0FVW $ - ;0B5:A-B5AB2HB# =040=><C 4V03=>AB8:C<V 28:>@8AB>2CTBLAO ?@8=F8? ;0B5:A=>W 03;NB8=0FVW. =B835= (;N4AL:89 30<<0-3;>1C;V=), I> 04A>@1>20=89 =0 =59B@0;L=8E G0AB8=:0E ;0B5:AC, 2ABC?0T 2 @50:FVN 03;NB8=0FVW 7 @52<0B>W4=8< D0:B>@>< (Ig M ?@>B8 Fc-D@03<5=BC Ig G). =B5=A82=VABL 03;NB8=0FVW ?@O<> ?@>?>@FV9=0 :V;L:>ABV $. !:;04 =01>@C 1. 5035=B 1. 0B5:A=0 ACA?5=7VO, 2 ml (<;) (1 HB.) 2. 5035=B 2. >7G8==8:, 14 ml (<;) (1 HB.) 3. 5035=B 3. >78B82=89 :>=B@>;L, O:89 <VAB8BL $ 1V;LH 12 IU/ml (4/<;), 0.2 ml (<;) (1 HB.) 4. 5035=B 4. 530B82=89 :>=B@>;L, O:89 <VAB8BL $ <5=H 12 IU/ml (4/<;), 0.2 ml (<;) (1 HB.) 5. 0;8G:8 4;O ?5@5<VHC20==O (100 HB.) 6. "5AB>289 A;094 (2 HB.) 7. =AB@C:FVO 7 28:>@8AB0==O 8. 0A?>@B =0;VB8G=V E0@0:B5@8AB8:8 'CB;82VABL B5ABC AB0=>28BL 12 IU/ml (4/<;) (03;NB8=0FVO =0 2+). !B0=40@B870FVO 28:>=0=0 ?> <V6=0@>4=><C AB0=40@BC $ NIBSC 64/002.255981-:B82>20=89 G0AB:>289 B@><1>?;0AB8=>289 G0A IVD (4V03=>AB8:0 in vitro ), =01V@, 0=0;V7 CB2>@5==O 73CAB:C"'-B5AB @V4:89 (100 287=)1HB01V@ "'-B5AB @V4:89 ?@87=0G5=89 4;O 28:>=0==O 107>2>W <5B>48:8 4>A;V465==O A8AB5<8 35<>AB07C - 287=0G5==O 0:B82>20=>3> ?0@FV0;L=>3> B@><1>?;0AB8=>2>3> G0AC ("' 01> '"'). !:;04 =01>@C 1. "' -@5035=B (@>7G8=, I> <VAB8BL D>AD>;V?V48 <>7:C :@>;8:0, 5;03>2C :8A;>BC, 1CD5@ V AB01V;V70B>@8), 10 ml (<;) - 1 D;. 2. 0;LFVN E;>@84 (0.277% @>7G8=), 10 ml (<;) - 1 D;. 3. =AB@C:FVO 7 28:>@8AB0==O. 4. 0A?>@B. =0;VB8G=V E0@0:B5@8AB8:8 "@820;VABL "' 2 :>=B@>;L=V9 ?;07<V 7 0B5AB>20=8< 7=0G5==O< 2 =>@<0;L=V9 >1;0ABV =0 :>03C;><5B@V, s (A), 2 <560E 24.2-36.4. >5DVFVT=B 20@V0FVW @57C;LB0BV2 287=0G5==O "' =5 ?5@528ICT 10%. >?CAB8<89 @>7:84 @57C;LB0BV2 287=0G5==O "' 2 >4=V9 ?@>1V ?;07<8 :@>2V @V7=8<8 =01>@0<8 >4=VTW A5@VW =5 ?5@528ICT 10%. "5AB GCB;8289 4> ?@8ACB=>ABV 2 :@>2V 0=B8:>03C;O=BV2. 0@0=BV9=89 B5@<V= 715@V30==O AB0=>28BL 18 mth (<VA) 7 4=O 283>B>2;5==O =01>@C. # @>7:@8B><C D;0:>=V "'-@5035=B ?>28=5= 7=0E>48B8AO ?@>BO3>< @>1>G>3> 4=O ?@8 :V<=0B=V9 B5<?5@0BC@V 18-25!, ?> 70:V=G5==V O:>3> @5035=B A;V4 715@V30B8 ?@8 B5<?5@0BC@V 2-8!. "0:5 G5@3C20==O B5<?5@0BC@=>3> @568<C 4>?CA:0TBLAO 4> ?>2=>3> 28B@0G0==O >1AO3C "'-@5035=BC ?@>BO3>< 1 mth (<VA).330590 01V@ @5035=BV2 4;O 28<V@N20==O <=>68==8E G8==8:V2 73>@B0==O IVD (4V03=>AB8:0 in vitro );07<0-:>=B@>;L ;>B , 4 ?0@0<5B@820HB 5035=B T ;V>DV;V7>20=>N 1V4=>N B@><1>F8B0<8 ?;07<>N :@>2V, 0B5AB>20=>N 70 4 ?0@0<5B@0<8 2 =>@<0;L=><C 4V0?07>=V. ;07<0->=B@>;L ;>B , 4 ?0@0<5B@8 70AB>A>2CNBL 4;O :>=B@>;N O:>ABV 0=0;V7V2 ?@8 4>A;V465==V A8AB5<8 35<>AB07C. ;07<0->=B@>;L ;>B , 4 ?0@0<5B@8 28:>@8AB>2CTBLAO 2 =0ABC?=8E B5AB0E: "'/'"'; ?@>B@><1V=>289 G0A; B@><1V=>289 G0A; DV1@8=>35= (<5B>4>< ;0CAA0). !:;04 =01>@C 1. ;07<0->=B@>;L ;>B , 4 ?0@0<5B@8 (;V>DV;L=> 28ACH5=0 :>=B@>;L=0 ?;07<0 :@>2V ;N48=8 7 =>@<0;L=8< 4V0?07>=>< 7=0G5=L), =0 1 ml (<;)  1 D;. 2. =AB@C:FVO 7 28:>@8AB0==O. 3. 0A?>@B. 0@0=BV9=89 B5@<V= 715@V30==O AB0=>28BL 15 mth (<VA) 7 4=O 283>B>2;5==O =01>@C. 0O2=0 <>6;82VABL 70<>@>6C20==O458237 CD5@=89 @>7G8==8: 7@07:V2 IVD (4V03=>AB8:0 in vitroPoG8==8: DIL-E (20 JI)3HB>2=VH=V9 283;O4: @5035=B T ?@>7>@>N @V48=>N 157 >A04C, 3@0=C; B0 D;>:C;. <VAB =5BB>: !?5F8DV:0FVW @5035=BC - 20 L (;) V0?07>= - 0-1,0% (1 L(;) d" V d" 20 L(;)) !?5F8DV:0FVW @5035=BC ?@54AB02;5=V 9>3> >1 T<><: @ - 7,60 0,20 25,0 1,0! @>2V4=VABL - 16,00 0,50 mS/cm (<!/c<) A<>B8G=89 B8A: - 310 10 mOsm/kg (<A</:3) 0O2=VABL 30@0=BV9=>3> ;8AB0 2V4 28@>1=8:0 01> 9>3> >DVFV9=>3> ?@54AB02=8:0 2 #:@0W=V ?@> <>6;82VABL ?>AB0G0==O B0 B5@<V= ?>AB0G0==O B>20@C (=040B8 >@83V=0; 2V4?>2V4=>3> 4>:C<5=BC 2 A:;04V ?@>?>78FVW). 555859 V4@0EC=>: ;59:>F8BV2 IVD (4V03=>AB8:0 in vitro ), @5035=BPo7G8= ;V7CNG89 LYE-I (500 MJI)3HB>2=VH=V9 283;O4: @5035=B T ?@>7>@>N @V48=>N 157 >A04C, 3@0=C; B0 D;>:C; 1 T<: !?5F8DV:0FVW @5035=BC - 500 mL (<;) V0?07>= - 0-1,5% (500 mL(<;) d" V d" 1 L(;)) @ -4,20 0,20 25,0 1,0! >268=0 E28;V ?V:C 01A>@1FVW - max 7=0E>48BLAO 2 4V0?07>=V 536 10 nm (=<) 0O2=VABL 30@0=BV9=>3> ;8AB0 2V4 28@>1=8:0 01> 9>3> >DVFV9=>3> ?@54AB02=8:0 2 #:@0W=V ?@> <>6;82VABL ?>AB0G0==O B0 B5@<V= ?>AB0G0==O B>20@C (=040B8 >@83V=0; 2V4?>2V4=>3> 4>:C<5=BC 2 A:;04V ?@>?>78FVW). 655866 V4@0EC=>: :;VB8= :@>2V IVD (4V03=>AB8:0 in vitro ), :>=B@>;L=89 <0B5@V0;Boule >=B@>;L-8D. >@<0;L=89 4,5 <;3HB !C<VA=VABL 7 0=0;V70B>@>< Swelab Alfa B0 Medonic M, ?@87=0G5=89 4;O 74V9A=5==O :>=B@>;L=8E 28<V@N20=L, =>@<0;L=89 @V25=L 0O2=VABL 30@0=BV9=>3> ;8AB0 2V4 28@>1=8:0 01> 9>3> >DVFV9=>3> ?@54AB02=8:0 2 #:@0W=V ?@> <>6;82VABL ?>AB0G0==O B0 B5@<V= ?>AB0G0==O B>20@C (=040B8 >@83V=0; 2V4?>2V4=>3> 4>:C<5=BC 2 A:;04V ?@>?>78FVW). 752867 - =>68==V 5;5:B@>;VB8 IVD (4V03=>AB8:0 in vitro), :0;V1@0B>@ 01V@ @5035=BV2 (0;V1@0=B A, 0;V1@0=B B)3HB@87=0G5==O:2-B>G:>25 :0;V1@C20==O, 2840;5==O 2V4E>4V2. ;O 4V03=>AB8:8Invitro. "5<?5@0BC@0 715@V30==O (0-40C). 5035=B ?>28=5= 1CB8 ?@>7>@8<. 0O2=VABL 30@0=BV9=>3> ;8AB0 2V4 28@>1=8:0 01> 9>3> >DVFV9=>3> ?@54AB02=8:0, 48;5@0, 48AB@81 NB>@0 2 #:@0W=V ?@> <>6;82VABL ?>AB0G0==O B0 B5@<V= ?>AB0G0==O B>20@C (=040B8 >@83V=0; 2V4?>2V4=>3> 4>:C<5=BC 2 A:;04V ?@>?>78FVW) 859058 - 89=89/ >G8IC20;L=89 @>7G8= IVD (4V03=>AB8:0 in vitro) 4;O 02B><0B87>20=8E/=0?V202B><0B87>20=8E A8AB5<  >7G8= 4;O ?@><820==O (0:B820FV9=89)1HB@87=0G5==O:4;O 0:B820FVW 9>=-A5;5:B82=8E 5;5:B@>4V2. ;O 4V03=>AB8:8Invitro. "5<?5@0BC@0 715@V30==O (0-40C). 5035=B ?>28=5= 1CB8 ?@>7>@8<. 0O2=VABL 30@0=BV9=>3> ;8AB0 2V4 28@>1=8:0 01> 9>3> >DVFV9=>3> ?@54AB02=8:0, 48;5@0, 48AB@81 NB>@0 2 #:@0W=V ?@> <>6;82VABL ?>AB0G0==O B0 B5@<V= ?>AB0G0==O B>20@C (=040B8 >@83V=0; 2V4?>2V4=>3> 4>:C<5=BC 2 A:;04V ?@>?>78FVW)959058 - 89=89/ >G8IC20;L=89 @>7G8= IVD (4V03=>AB8:0 in vitro) 4;O 02B><0B87>20=8E/=0?V202B><0B87>20=8E A8AB5<  >7G8= 4;O ?@><820==O (45?@>B5W=V7CNG89))2HB@87=0G5==O:4;O 45?@>B5W=V70FVW 9>=-A5;5:B82=8E 5;5:B@>4V2. (4;O 0=0;V70B>@0 5;5:B@>;VBV2 E- ?>;C02B><0BV7V20==8E A8AB5< lyte 5 plus). ;O 4V03=>AB8:8Invitro. "5<?5@0BC@0 715@V30==O =57<VH0=89 (0-40C), 7<VH0=89 (2-8C) =5 1V;LH5 2-E B86=V2. 5035=B ?>28=5= 1CB8 ?@>7>@8<. 0O2=VABL 30@0=BV9=>3> ;8AB0 2V4 28@>1=8:0 01> 9>3> >DVFV9=>3> ?@54AB02=8:0, 48;5@0, 48AB@81 NB>@0 2 #:@0W=V ?@> <>6;82VABL ?>AB0G0==O B0 B5@<V= ?>AB0G0==O B>20@C (=040B8 >@83V=0; 2V4?>2V4=>3> 4>:C<5=BC 2 A:;04V ?@>?>78FVW)1054873 =B8:0@4V>;V?V=, 0=B8BV;0 IVD (4V03=>AB8:0 in vitro ), @5035=B01V@ @5035=BV2 4;O  (RPR 01)3HB;O 28O2;5==O @503V=>28E 0=B8BV; 4> Treponema pallidum 2 A8@>20BFV B0 ?;07<V :@>2V ;N48=8 2 @50:FVW <V:@>?@5F8?VB0FVW ( ). 01V@ ?>28=5= <VAB8B8 :0@4V>;V?V=>289 0=B835=, E>;V=-E;>@84 =0 V7>B>=VG=><C @>7G8=V =0B@VN E;>@84C V ?>78B82=89 :>=B@>;L (V=0:B82>20=0 A8@>20B:0, O:0 <VAB8BL 0=B8BV;0 4> :0@4V>;V?V=>2>3> 0=B835=C). 0@4V>;V?V=>289 0=B835= - ACA?5=7VO 2 10% @>7G8=V E>;V=-E;>@84C B@L>E 28A>:>>G8I5=8E ;V?V4V2: :0@4V>;V?V=C, ;5F8B8=C B0 E>;5AB5@8=C 2 01A>;NB=><C 5B8;>2><C A?8@BV. @8=F8? 0=0;V7C: C 0=B835==8E AB@C:BC@0E Treponema pallidum T ;V?>?@>B5W=>2V 0=B835=8, C 2V4?>2V4L =0 O:V 2 >@30=V7<V E2>@>3> D>@<CNBLAO 0=B8BV;0 :;0AC IgM V IgG (@503V=8). =B835==89 :><?;5:A :0@4V>;V?V=C, ;5F8B8=C V E>;5AB5@8=C 740B=89 72'O7C20B8AO 7 @503V=0<8, I> V @5TAB@CTBLAO 2 @50:FVW <V:@>?@5F8?VB0FVW (28?040==O ?;0ABV2FV2 @V7=>W 25;8G8=8). !:;04 =01>@C ?>28=5= 1CB8 @>7@0E>20=89 =0 500 4>A;V465=L (2:;NG0NG8 :>=B@>;V) B0 <VAB8B8: 1) 0@4V>;V?V=>289 0=B835= 1 <; ?@5?0@0BC ?>28=5= <VAB8B8: :0@4V>;V?V=  0,03 %, ;5F8B8=  0,27 %, E>;5AB5@8=  0,9 % 2 01A>;NB=><5 5B8;>2><C A?8@BV. @>7>@89 15710@2=89 @>7G8= 7 E0@0:B5@=8< 70?0E>< A?8@BC; 2) >7G8= E>;V=-E;>@84C: E>;V=-E;>@84 - 70% 2 0,9% @>7G8=V =0B@VN E;>@84C. @>7>@89 15710@2=89 @>7G8= 7 E0@0:B5@=8< 70?0E><; 3) >78B82=89 :>=B@>;L 4+ >B>289 4> 28:>@8AB0==O. =0:B82>20=0 A8@>20B:0, O:0 <VAB8BL 0=B8BV;0 4> :0@4V>;V?V=>2>3> 0=B835=C. "8B@ @503V=>28E 0=B8BV; 4> T.pallidum T 4>AB0B=V< 4;O >B@8<0==O ?>78B82=>3> @57C;LB0BC 4+ 2  (A2VB;>-6>2B89). 4) V6 0<?C;L=89 (70 C<>2 28:>@8AB0==O 0<?C; 7 :V;LF5< G8 B>G:>N >1;><C =0O2=VABL A:0@8DV:0B>@C =5 >1>2 O7:>20). $>@<0 28?CA:C <0T 1CB8: :0@4V>;V?V=>289 0=B835= @>7D0A>20=89 C A:;O=V 0<?C;8 (5 2 <;), E>;V=-E;>@84 @>7D0A>20=89 C A:;O=V D;0:>=8 (1 5 <;)., ?>78B82=89 :>=B@>;L (1 E 1 <;). 030;L=89 B5@<V= ?@840B=>ABV  =5 <5=H5 1 @>:C. 01V@ <0T 715@V30B8AL V B@0=A?>@BC20B8AL 2 70E8I5=><C 2V4 A2VB;0 <VAFV 70 B5<?5@0BC@8 2-8C. >6;82VABL B@0=A?>@BC20==O 70 B5<?5@0BC@8 9-25! ?@>BO3>< 45AOB8 4V1. #G0A=8: ?>28=5= =040B8 ;8AB 28po1=8:0 01> 9>3> >DVFV9=>3> ?@54AB02=8:0, O:8< ?V4B25@46CTBLAO <>6;82VABL ?>AB02:8 70?@>?>=>20=>3> B>20@C.1154518 ;N:>70 A5GV IVD (4V03=>AB8:0 in vitro ), =01V@, :>;>@8<5B@8G=0 B5AB-A<C6:0, 5:A?@5A0=0;V7!<C6:8 V=48:0B>@=V ;N:>B5AB !1005HB=48:0B>@=89 H0@ A<C6>: ";N:>B5AB" O2;OT A>1>N A<C6:C DV;LB@C20;L=>3> ?0?5@C, O:C ?@>A>G5=> EV<VG=8<8 @5G>28=0<8, 4> A:;04C O:8E 2E>48BL: 3;N:>7>>:A84070 - 0,000026 3; ?5@>:A84070 - 0,0000018 3; B5B@0<5B8;15=7848= - 0,000085 3; =48:0B>@=V A<C6:8  ;N:>B5AB ?@87=0G5=V 4;O 287=0G5==O 2<VABC 3;N:>78 C A5GV ;N48=8. V;O=:8 :>;L>@>2>W H:0;8 =0 5B8:5BFV  ;N:>B5AB 2V4?>2V40NBL B0:8< ?>:07=8:0< 3;N:>78 C A5GV (%): 0 0,1 0,5 1,0 2,0 1246795- 03=V9 (Mg2 +) IVD (4V03=>AB8:0 in vitro ), =01V@,A?5:B@>D>B><5B@8G=89 0=0;V703=V9 !?1C?03=V9 CB2>@NT ?C@?C@=89 7010@2;5=89 :><?;5:A, :>;8 2ABC?0T 2 @50:FVN 7 <03>= AC;LD>=0B>< 2 ;C6=><C A5@54>28IV. =B5=A82=VABL :>;L>@C ?@>?>@FV9=0 :>=F5=B@0FVW <03=VN 2 7@07:C. !:;04 =01>@C 1. 5035=B 1. 0@2=8:: :A8;V4V;>289 1;0:8B=89 - 0.1 mmol/l (<<>;L/;); BV>3;V:>;520 :8A;>B0 - 0.7 mmol/l (<<>;L/;); ! - 3000 mmol/l (<<>;L/;). 2. !B0=40@B. >4=89 @>7G8= <03=VN - 0.824 mmol/l (<<>;L/;). 3. =AB@C:FVO 7 28:>@8AB0==O. 4. 0A?>@B. =0;VB8G=V E0@0:B5@8AB8:8 1. V=V9=VABL 28<V@N20;L=>3> 4V0?07>=C: 0.2 - 2.1 mmol/l (<<>;L/;). V4E8;5==O 2V4 ;V=V9=>ABV =5 ?5@528ICT 3%. /:I> >B@8<0=V @57C;LB0B8 1C;8 1V;LH5, =V6 <56V ;V=V9=>ABV, @>7254VBL 7@07:8 1:1 (2 420 @078) NaCl 9 g/l (3/;) B0 ?><=>6B5 @57C;LB0B =0 420. 2. 'CB;82VABL =5 <5=H 0.2 mmol/l (<<>;L/;). 3 .>5DVFVT=B 20@V0FVW @57C;LB0BV2 287=0G5=L  =5 1V;LH 3%.1354313 @>:0;LF8B>=V= IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>D;N>@5AF5=B==89 0=0;V7W210 "5AB-A8AB5<0 Finecare 4;O :V;L:VA=>W 5:A?@5A 4V03=>AB8:8 ?@>:0;LF8B>=V=C2C?@87=0G5==O: 4;O :V;L:VA=>W 5:A?@5A-4V03=>AB8:8 <5B>4>< D;C>@5AF5=B=>3> V<C=>0=0;V7C in vitro =0 0=0;VB8G=V9 A8AB5<V Finecare FIA meter V0?07>= B5ABC20==O: 0.1-100 =3/<; 0B5@V0; ?@>18: FV;L=0 :@>2, ?;07<0, A8@>20B:0 0O2=VABL 30@0=BV9=>3> ;8AB0 2V4 28@>1=8:0 01> 9>3> >DVFV9=>3> ?@54AB02=8:0, 48;5@0, 48AB@81 NB>@0 2 #:@0W=V ?@> <>6;82VABL ?>AB0G0==O B0 B5@<V= ?>AB0G0==O B>20@C (=040B8 >@83V=0; 2V4?>2V4=>3> 4>:C<5=BC 2 A:;04V ?@>?>78FVW)1461010 ;V:>78;L>20=89 35<>3;>1V= (HbA1c) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7W207 "5AB-A8AB5<0 Finecare 4;O :V;L:VA=>W 5:A?@5A 4V03=>AB8:8 ;V:>20=>3> 35<>3;>1V=C1C?@87=0G5==O: 4;O :V;L:VA=>W 5:A?@5A-4V03=>AB8:8 <5B>4>< D;C>@5AF5=B=>3> V<C=>0=0;V7C in vitro =0 0=0;VB8G=V9 A8AB5<V Finecare V0?07>= B5ABC20==O: 4.0-14.5% 0B5@V0; ?@>18: FV;L=0 :@>2 0O2=VABL 30@0=BV9=>3> ;8AB0 2V4 28@>1=8:0 01> 9>3> >DVFV9=>3> ?@54AB02=8:0, 48;5@0, 48AB@81 NB>@0 2 #:@0W=V ?@> <>6;82VABL ?>AB0G0==O B0 B5@<V= ?>AB0G0==O B>20@C (=040B8 >@83V=0; 2V4?>2V4=>3> 4>:C<5=BC 2 A:;04V ?@>?>78FVW)1558769 $5@8B8= IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>D;C>@5AF5=B=89 0=0;V7W269 "5AB-A8AB5<0 Finecare 4;O :V;L:VA=>W 5:A?@5A 4V03=>AB8:8 $5@8B8=C1C?@87=0G5==O: 4;O :V;L:VA=>W 5:A?@5A-4V03=>AB8:8 <5B>4>< D;C>@5AF5=B=>3> V<C=>0=0;V7C in vitro =0 0=0;VB8G=V9 A8AB5<V Finecare FIA meter V0?07>= B5ABC20==O: 5-1000 =3/<; 0B5@V0; ?@>18: FV;L=0 :@>2, ?;07<0, A8@>20B:0 0O2=VABL 30@0=BV9=>3> ;8AB0 2V4 28@>1=8:0 01> 9>3> >DVFV9=>3> ?@54AB02=8:0, 48;5@0, 48AB@81 NB>@0 2 #:@0W=V ?@> <>6;82VABL ?>AB0G0==O B0 B5@<V= ?>AB0G0==O B>20@C (=040B8 >@83V=0; 2V4?>2V4=>3> 4>:C<5=BC 2 A:;04V ?@>?>78FVW)1647869 =>68==V 0=0;VB8 :;V=VG=>W EV<VW IVD, :>=B@>;L=89 <0B5@V0;@525:0; - V>EV<VO (N4AL:0) (12x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z |  ȶssL(FhQ5B*OJQJ\^J_H"fHmHnH"phq sHtH"LhQhQ5B*OJQJ\^J_H"fHmHnH"phq sHtH">hQ5B*OJQJ\^J_H"fHnH"phq tH"DhQhQ5B*OJQJ\^J_H"fHnH"phq tH"#h+qh+q5OJQJ^JnH"tH"hhGOJQJ^Jh+rhGOJQJ^Jh+rh+qOJPJQJ^Jh+rh9OJPJQJ^JJL  ""L#|$&''''}$a$gdigdi&$ 2( Px 4 #\'*.25@9`a$gdi"$ 2( Px 4 #\'*.25@9a$gdi$a$gdQ $`a$gde $ Aa$gd+qgd$a$gd  P T   J L d f h l   N R N R T བrབr[r,hQhQCJOJPJQJ^JaJnHtHFhQ5B*OJQJ\^J_H"fHmHnH"phq sHtH"LhQhQ5B*OJQJ\^J_H"fHmHnH"phq sHtH"DhQhQ5B*OJQJ\^J_H"fHnH"phq tH">hQ5B*OJQJ\^J_H"fHnH"phq tH"# "&J "$~hjl(,vz $z~ཽཽཽཽ{ཽ4hQhQCJKHOJPJQJ^J_H9aJnHtHLhQhQ5B*OJQJ\^J_H"fHmHnH"phq sHtH"DhQhQ5B*OJQJ\^J_H"fHnH"phq tH">hQ5B*OJQJ\^J_H"fHnH"phq tH"0.bfh $|~bfjDFŢࢢ_______>h45B*OJQJ\^J_H"fHnH"phq tH"Dh4h45B*OJQJ\^J_H"fHnH"phq tH"DhQhQ5B*OJQJ\^J_H"fHnH"phq tH"4hQhQCJKHOJPJQJ^J_H9aJnHtH>hQ5B*OJQJ\^J_H"fHnH"phq tH"FH  Nhjl vz $|~  & ( L N ¢¢¢¢¢¢¢¢¢¢¢¢¢¢¢¢¢¢>h45B*OJQJ\^J_H"fHnH"phq tH">he5B*OJQJ\^J_H"fHnH"phq tH"Dhehe5B*OJQJ\^J_H"fHnH"phq tH"4heheCJKHOJPJQJ^J_H9aJnHtH3N | ~ !$!j!n!v!!!" ""Z"^""""""J#L#ݽݽݽݽݽݽݽݽݝz``EE4hi5CJOJPJQJ\^JaJmHnHsHtH2hQhQ6CJOJPJQJ]^JaJnHtHDhQhQ5B*OJQJ\^J_H"fHnH"phq tH">hQ5B*OJQJ\^J_H"fHnH"phq tH">he5B*OJQJ\^J_H"fHnH"phq tH"Dhehe5B*OJQJ\^J_H"fHnH"phq tH"L#R#T####$&$P$T$x$z$|$%@&&&'''''''''''''''蹢r[[[,hi5CJOJPJQJ\^JaJnHtH4hi6CJOJPJQJ]^JaJmHnHsHtH)hiCJOJPJQJ\^JaJnHtH,hi5CJOJPJQJ\^JaJnHtH4hi5CJOJPJQJ\^JaJmHnHsHtH&hiCJOJPJQJ^JaJnHtH.hiCJOJPJQJ^JaJmHnHsHtH''''(,(4( $$Ifa$'''''( ((*(,(2(4(6(8(:(x(z((((()))) ))***+l+n+++++,H,J,,, -ιέΘkk&hiCJOJPJQJ^JaJnHtH1hiCJOJPJQJ\^JaJmHnHsHtH)hiCJOJPJQJ\^JaJnHtHhiCJaJnH"tH")hi5CJOJPJQJ^JaJnHtH,hi5CJOJPJQJ\^JaJnHtH4hi5CJOJPJQJ\^JaJmH nHsH tH*4(6(kd$$Iflֈ!Y/F&f7Ff/ fFRF  t<+44 lBap<yti6(:(z((()))*n+++J,, ---.N..../ lad $If]a l`d $If]`$If $$Ifa$ - ------..L.N.......//////00>000000011>2d2f2~22x3z3334 4"484:4>4p4r4>6>8>:;;<><>>>>>>>N?P??????곳&hiCJOJPJQJ^JaJnHtH,hi5CJOJPJQJ\^JaJnHtHhiCJaJnH"tH")hiCJOJPJQJ\^JaJnHtHF///00001^UUUJUU d$If $$Ifa$kd$$Iflֈ!Y/F&f7Ff/ fFRF t+44 lBayti1f22z33"4:4r4;>>Xkd$$Iflֈ!Y/F&f7Ff/ fFRF t+44 lBayti$If >>P???@@CC>DzDDtE d$If$If $$Ifa$ ?@@@>@>BCCCCDxDzDDDrEtEvExEzEEEFFF F"F&F(F>FFFFFGGGDGFGRGTG`GbGjGlGGG HH>H^H`HHH>JLJNJPJRJTJVJXJJֲֲֲ֢hiCJOJPJQJ^JaJ.hiCJOJPJQJ^JaJmHnHsHtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtH)hiCJOJPJQJ\^JaJnHtH@tEvEzEEF"F(FFF^UUOUUFF d$If$If $$Ifa$kd2$$Iflֈ!Y/F&f7Ff/ fFRF t+44 lBaytiFG>GlGGH`HHNJPJRJ$If { $1$7$8$If "d$If]" d$If RJTJXJJKK$KKK^UUOUUFF d$If$If $$Ifa$kdi$$Iflֈ!Y/F&f7FF/ ffR t+44 lBaytiJJKKKK"K$KKKKKKKKLL L L0L2LMMDNNNNNNNNNOONOPOxOzOOOOOOO쪪hihiCJaJnH"tH")hiCJOJPJQJ\^JaJnHtH)hiCJH*OJPJQJ^JaJnHtH.hiCJOJPJQJ^JaJmHnHsHtH&hiCJOJPJQJ^JaJnHtHMNN$If "d$If]" d$IfNNNOPOzOOOOO^UUUUOUUO$If $$Ifa$kd$$Iflֈ!Y/F&f7FF/ ffR t+44 lBayti OOO.PPPBQVRXRZR\R^R`RnRpRRRR S"S:SS@SBSDSHSJSSSTpTrTBU0V2V4V췣]]]HhiB*CJOJPJQJ^JaJfHmHnHphq sHtH@hiB*CJOJPJQJ^JaJfHnHphq tH'hiB*CJOJPJQJ^JaJph"""'hiB*CJOJPJQJ^JaJphhiCJaJnH"tH")hiCJOJPJQJ\^JaJnHtH&hiCJOJPJQJ^JaJnHtH$OPXRZR\R`ROF $$Ifa$kdu$$Iflֈ!Y/F&f7FF/ ffR t+44 lBayti d$If$If`RpRRR@SDSJSrT2V4V d$If$If $$Ifa$$$-DIfM a$ 4V6V8V:VHVJVrVtVVVVVWWWbWdWfWhWlWnWWX XXX̴cBccBB@hiB*CJOJPJQJ^JaJfHnHphq tHHhiB*CJOJPJQJ^JaJfHmHnHphq sHtH/hiB*CJOJPJQJ^JaJmH ph"""sH 'hiB*CJOJPJQJ^JaJph"""/hiB*CJOJPJQJ^JaJmHph"""sH'hiB*CJOJPJQJ^JaJph&hiCJOJPJQJ^JaJnHtHhiCJaJnH"tH"4V6V:VJVtVVVW[R@@@@@$$-DIfM a$ $$Ifa$kd.$$Iflֈ!Y/F&f7F/ ffR t+44 lBBaytiWWdWhWnWXRZTZCkd$$Iflֈ!Y/F&f7F/ ffRF t+44 lBBayti d$If$If $$Ifa$XYPZRZTZVZXZZZZZZZ[4[6[8[[[[[[[[[ֶa@@hiB*CJOJPJQJ^JaJfHnHphq tHHhiB*CJOJPJQJ^JaJfHmHnHphq sHtH/hiB*CJOJPJQJ^JaJmH ph"""sH /hiB*CJOJPJQJ^JaJmHph"""sH'hiB*CJOJPJQJ^JaJphhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtH)hiCJOJPJQJ\^JaJnHtHTZXZZZZ6[8[[[[\T\\]_$If$$-DIfM a$ $$Ifa$[\\\\R\T\\\\\\]]]<^________````V`X`Z`\```b`j`jbjdjfffgg`hjhi@i8j:jjj۲۲}hiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtH)hiCJOJPJQJ\^JaJnHtH@hiB*CJOJPJQJ^JaJfHnHphq tHhimHsHHhiB*CJOJPJQJ^JaJfHmHnHphq sHtH1____``X`\`b`[RRRRLRR$If $$Ifa$kd $$Iflֈ!Y/F&f7F/ ffRF t+44 lBBaytib`fg>i@i:jll\nq d$If jjlljlllZn\njnjpqqqqq(q*qDqJqfqvqqqr&r(r*r,r0r2rFsHssssstt t"t$tuuvvvv v vvvDvFvvvxvvvvvv7hiB*CJOJPJQJ^JaJmHnHphsHtH.hiCJOJPJQJ^JaJmHnHsHtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtH;qqq*qq(r,r2r^UUUOUU$If $$Ifa$kdk $$Iflֈ!Y/F&f7FF/ ffR t+44 lBayti2rHsss t"tuvv v $*$1$If $$*$1$Ifa$$$*$1$If^a$$ & Fd$*$1$Ifa$gdi & Fd$*$1$Ifgdi$d$Ifa$ v vvFvxvvvvvv^UUUUUOUU$If $$Ifa$kd$ $$Iflֈ!Y/F&f7FF/ ffR t+44 lBayti vvvvvvxxVxXxxx~yyyyyz2z4zJzLz~zz{ {{<|z|||||J}L}N}R}T}^}`}~}}}}}}}~~~~~~VXԼhiPJ^JmHnHsHtHhiPJ^JnHtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtH.hiCJOJPJQJ^JaJmH nHsH tHxXxxyy4zLzz {|||L} d$If L}N}T}`}}~~~^UUUOUUF d$If$If $$Ifa$kd $$Iflֈ!Y/F&f7FF/ ffRF t+44 lBaytiX ,OFFF $$Ifa$kd $$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti$If d$IfXā *,djlnrxR "ކ (8*,np̉Ή2L־־hiPJ^JmHnHsHtHhiPJ^JnHtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtH)hiCJOJPJQJ\^JaJnHtHD"FkdO $$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti$If d$If $$Ifa$,pΉ d$If$If $$Ifa$ ċ.@^UUUUUUUU $$Ifa$kd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti ‹ċ,.>@fhjlpr.ŽĎ ޏ "$(*.46VXvx46rt:<|~ҒԒU.hiCJKHOJPJQJ^J_H9aJnHtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtHI@hlrĎ" d$If $$Ifa$ "$*6Xx^UUUUUUUU $$Ifa$kd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti 6t<~Lkdz$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$Ԓ &2L, d$If $$Ifa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in vitro ), =01V@, @50:FVO 03;NB8=0FVW"5AB-@5035=B Anti-Salmonella I ( - +Vi) 1<;1D;0:!C<VH <>=>:;>=0;L=8E 0=B8BV;0 4> A><0B8G=>3> () 0=B835=C A5@>20@V2 A E 4;O A5@>;>3VG=>W V45=B8DV:0FVW HB0<V2 Salmonella 2 @50:FVW 03;NB8=0FVW =0 A:;V; V>DV;V70B, 01> @V48=0; 57 >7=0: 7@>AB0==O 10:B5@V9 01> 3@81V2, >A04C V V=H8E AB>@>==VE 4><VH>:; !B01V;L=VABL: -ACE89 @5035=B ?VA;O @>72545==O - =5 <5=H5 18 <VAOFV2, -@V4:89 @5035=B ?VA;O 2V4:@8BBO - =0 ?@>BO7V 2AL>3> B5@<V=C ?@840B=>ABV 28@>1=8:0; #?0:>2:0 - ?> 1 D;\1 <;, ?V?5B:0 2 :><?;5:BV; 0@0=BV9=89 ;8AB 2V4 28@>1=8:0 01> ?@54AB02=8: =0 #:@0W=V 7 ?V4B25@465==O< <>6;82>ABV ?>AB02:820 51643 Shigella flexneri 7030;L=V 0=B8BV;0 IVD, @5035=B"5AB-@5035=B Anti-Shigella I (S. flexneri, B8? 1 4> 6, 3@C?0 3,4(y), 6 V 7,8(x) 0 B0:>6 S. sonnei S- V F-D>@<8) 1<;1D;0:"5AB-@5035=B8 ?@87=0G5=V 4;O A5@>;>3VG=>W 45B5:FVW B0 287=0G5==O A5@>20@0 HB0<V2 Shigella, <VABOBL 0=B8BV;0 S. flexneri, B8? 1 4> 6, 3@C?0 3,4(y), 6 V 7,8(x) 0 B0:>6 S. sonnei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in vitro );07<0 :@>;OG0 F8B@0B=0 ACE0, 10 0<?C; ?> 1 <;1=01V@/2;OT A>1>N ;V>DV;V7>20=C ?;07<C :@>;OGC F8B@0B=C >B@8<0=C 7 :@>2V :@>;8:V2 H;OE>< 7<VHC20==O 7 10% @>7G8=>< =0B@VN ;8<>==>:8A;>3>. $>@<0 28?CA:C 2 0<?C;0E.2237435 8A: IVD (4V03=>AB8:0 in vitro ) 4;O 28?@>1C20==O =0 A?@89=OB;82VABL 4> 078B@><VF8=C8A:8 SD204 Azithromycin / 78B@><VF8= 15 <:31D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << 7 =04@C:>20=8< AZM 15 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V22345445 <V:0F8=>2V 48A:8 4;O B5ABC20==O =0 GCB;82VABL, IVD (4V03=>AB8:0 in vitro )8A:8 SD035 Amikacin/<V:0F8= 30 <:3.2 D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< AK 10 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V22446191 <?VF8;V=>2V 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD002 Ampicillin/<?VF8;V= 10 <:3.2D;0:>=8A:8 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< AMP 10 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V22559213 0=:><VF8=, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD045 Vancomycin/0=:><VF8= 30 <:3.2D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< VA 30 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V22645529 5=B0<VF8=>2V 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD016 Gentamicin / 5=B0<VF8= 10 <:3.2 D;0:>=8A:8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< GEN 10 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V22738575 >:A8F8:;V= 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD012 Doxycycline Hydrochloride / >:A8F8:;V= 30 <:3.2D;0:>=8A:8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< DO 30 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V22841910 8A: IVD (4V03=>AB8:0 in vitro ) 48A:@5B870FVW A?@89=OB;82>ABV 4> 5@8B@><VF8=C8A:8 SD013 Erythromycin 15 mcg / @8B@><VF8= 15 <:3.1 D;0:>=8A:8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< E 15 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V22961975 B@0:>=07>;, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD276 Itraconazole / B@0:>=07>; 30 <:3.1 D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ?@>B83@81:>28E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< IT 30 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V23061976 5B>:>=07>;, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD224 Ketoconazole/5B>:>=07>; 10 <:3.1 D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ?@>B83@81:>28E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< KT 10 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V23145390 8A: :;V=40<VF8=C 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD051 Clindamycin / ;V=40<VF8= 2 <:3.1D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< CD 2 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V23262022 ;>B@8<07>;, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD115 Clotrimazole / ;>B@8<07>; 10 <:3.1D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ?@>B83@81:>28E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< CC 10 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V23359199 !C;LD0<5B>:A07>;/ B@8<5B>?@8<, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD010 Co-Trimoxazole25 mcg (Trimethoprim/Sulphamethoxazole) (1.25/23.75 mcg) / >-B@8<>:A07>; 25 <:3 ("@8<5B>?@8</!C;LD0<5B>:A07>; 25 <:3 1.25/23).1D;0:>=8A:8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< !OT 25 (1.25/23.75 mcg) C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V23461977 V:>=07>;, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD272 Miconazole/V:>=07>; 50 <:3.1D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ?@>B83@81:>28E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< MIC 50 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V23559164 VAB0B8=, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD025 Nystatin NS 100 Units/VAB0B8= 100 >48=8FL.1D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ?@>B83@81:>28E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< NS 100 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V23659159 VB@>DC@0=B>W=, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD023 Nitrofurantoin / VB@>DC@0=B>W= 300 <:3.2D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< NIT 300 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V23759162 >@D;>:A0F8=, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD057 Norfloxacin/>@D;>:A0F8= 10 <:3.2D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< NX 10 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V23859168 :A0F8;V=, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD088 Oxacillin/:A0F8;V= 1 <:3.2 D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< OX 1 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V2399173 5=VF8;V=/=>2>1V>F8=, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD028 Penicillin-G P 10 / 5=VF8;V= (5=78;?5=VF8;V=) 10 >48=8FL.2D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< P 10 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V24059183 8D0<?VF8=, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD030 Rifampicin / VD0<?VF8= 5 <:3. 100 48A:V2 C D;0:>=V.1D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< RIF 5 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V24159193 !B@5?B><VF8=, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD031 Streptomycin / !B@5?B><VF8= 10 <:3.1D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< S 10 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V24259209 ">1@0<VF8=, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD154 Tobramycin (">1@0<VF8=)2D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 <<. $0AC20==O 100 48A:V24342830 8A:8 4;O B5ABC20==O =0 GCB;82VABL 7 D;C:>=07>;><, IVD (4V03=>AB8:0 in vitro )8A:8 SD114 Fluconazole/$;N:>=07>; 10 <:3.1 D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ?@>B83@81:>28E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< FLC 10 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V24438567 8A: IVD (4V03=>AB8:0 in vitro ) 4;O 4V03=>AB8:8 GCB;82>ABV 4> E;>@0<D5=V:>;C8A:8 SD006 Chloramphenicol / %;>@0<D5=V:>; 30 <:3.2D;0:>=8A:8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 284: 1C<06=V 48A:8 4V0<5B@>< 6 << 7 =04@C:>20=8< ! 30 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V24540755 8A: IVD (4V03=>AB8:0 in vitro ) 4;O 4V03=>AB8:8 GCB;82>ABV 4> F5D07>;V=C8A:8 SD047 Cefazolin/&5D07>;V= 30 <:3.2 D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: ?0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< CZ 30 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V24637573 &5D5?V< <V=V<0;L=0 V=3V1C20;L=0 :>=F5=B@0FVO IVD (4V03=>AB8:0 in vitro )8A:8 SD219 Cefepime / &5D5?V< 30 <:3.2D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< CPM 30 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V24738657 &5D>?5@07>=/AC;L10:B0< <V=V<0;L=0 V=3V1C20;L=0 :>=F5=B@0FVO IVD (4V03=>AB8:0 in vitro )8A:8 SD203 Cefoperazone/Sulbactam / &5D>?5@07>=/!C;L10:B0< 75/30 <:3 (!C;L?5@07>=). 2 D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< CFS 75/30 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V24846005 &5D>B0:A8<>2V 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD040 Cephotaxime / &5D>B0:A8< 30 <:3.2D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< !TX 30 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V24937441 8A: IVD (4V03=>AB8:0 in vitro ) 4;O 28?@>1C20==O =0 A?@89=OB;82VABL 4> F5DB07848<C8A:8 SD062 Ceftazidime / &5DB07848< 30 <:3.2 D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< CAZ 30 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V25044483 8A:8 4;O B5ABC20==O =0 GCB;82VABL 7 F5DB@V0:A>=><, IVD (4V03=>AB8:0 in vitro )8A:8 SD065 Ceftriaxone / &5DB@V0:A>= 30 <:3. 100 48A:V2 C D;0:>=V.2D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< CTR 30 2 F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V25142487 8A:8 4;O B5ABC20==O =0 GCB;82VABL 7 F5DC@>:A8<>< =0B@VN, IVD (4V03=>AB8:0 in vitro )8A:8 SD061 Cefuroxime / &5DC@>:A8< 30 <:3. 100 48A:V2 C D;0:>=V.2D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< CXM 30 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V25245359 &8?@>D;>:A0F8=>2V 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )8A:8 SD060 Ciprofloxacin / &8?@>D;>:A0F8= 5 <:3.2D;0:>=8A:8 7 0=B81V>B8:0<8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> 0=B8<V:@>1=8E ?@5?0@0BV2. >2=VH=V9 283;O4: 0?5@>2V 48A:8 4V0<5B@>< 6 << V7 =04@C:>20=8< CIP 5 C F5=B@V :>6=>W AB>@>=8 48A:0. $0AC20==O 100 48A:V25362451 Escheric hia coli, G8A;5== V HB0<8, 0=B835= 8 V7>;OBC :C;LBC@ 8 IVD (4V03=>A B8:0 in vitro), =01V@, @50:FVO 03;NB8= 0FVW=B8 A8@>20B:0 E. coli I ?>;V20;5=B=0, 1 <; (O25:K11,O26:K60,O44:K7 4,O55:K59,O78:K80,O111: K58,O114:K-,O119:K69)3D;0:>==B8 A8@>20B:0 E. coli I ?>;V20;5=B=0 (O25:K11,O26:K60,O44:K74,O55:K59,O78:K80, O111:K58,O114:K-,O119:K69) =B8 A8@>20B:0 E. coli II ?>;V20;5=B=0 (O86:K61,O124:K72,O125:K70,O126:K71,O127: K63,O128:K67) =B8 A8@>20B:0 E. coli III ?>;V20;5=B=0 (O18a O18c:K77, O20a O20b:K84,O28:K73,O112a O112c:K66) @87=0G5=V 4;O A5@>;>3VG=>W V45=B8DV:0FVW HB0<V2 E. Coli 7 4>A;V46C20=>3> <0B5@V0;C =0 >A=>2V <5B>4C 03;NB8=0FVW =0 ?@54<5B=><C A:;V. ;O ?>2=>W V45=B8DV:0FVW E. coli =5>1EV4=5 284V;5==O :C;LBC@8, 1V>EV<VG=>W E0@0:B5@8AB8:8 B0 A5@>B8?C20==O. !:;04:?>;V:;>=0;L=V 0=B8BV;0, >B@8<0=V H;OE>< V<C=V70FVW :@>;8:V2 AB0=40@B=8<8 HB0<0<8. "5@<V= ?@840B=>ABV: 2 @>:8. V4:V A8@>20B:8 715@V30NBL A2>W 2;0AB82>ABV ?@>BO3>< CAL>3> B5@<V=C ?@840B=>ABV. '8==0 45:;0@0FVO ?@> 2V4?>2V4=VABL, V=AB@C:FVO =040TBLAO C A:;04V ?@>?>78FVW 45@602=> <>2>N. V4?>2V4=VABL B5E=VG=><C @53;0<5=BC I>4> <548G=8E 28@>1V2 4;O 4V03=>AB8:8 in vitro. CG0A=8: C A:;04V B5=45@=>W ?@>?>78FVW ?>28=5= =040B8 4>:C<5=B, I> ?V4B25@46CT =0O2=VABL ?0@B=5@AL:8E 2V4=>A8= 7 28@>1=8:>< (?@54AB02=8FB2><, DV;VTN 28@>1=8:0  O:I> WE 2V4?>2V4=V ?>2=>2065==O ?>H8@NNBLAO =0 B5@8B>@VN #:@0W=8), 01> ?@54AB02=8:><, 48;5@><, 48AB@81 NB>@><, >DVFV9=> C?>2=>2065=8< =0 F5 28@>1=8:><, O:8< ?V4B25@46CTBLAO <>6;82VABL ?>AB02:8 CG0A=8:>< B>20@C, O:89 T ?@54<5B>< 40=>W ?@>F54C@8 70:C?V2;V, C :V;L:>ABV, B0 2 B5@<V=8, 287=0G5=V FVTN "5=45@=>N 4>:C<5=B0FVTN. >:C<5=B ?>28=5= 1CB8 4V9A=8< =0 25AL B5@<V= ?>AB0G0==O ?@>4C:FVW B0 >1>2 O7:>2> <VAB8B8 30@0=BVW 28@>1=8:0 I>4> O:>ABV ?@>4C:FVW(;8AB ?>28=5= <VAB8B8 ?>A8;0==O =0 =><5@ >3>;>H5==O ?@> ?@>2545==O 2V4:@8B8E B>@3V2)(=040NBL 2AV CG0A=8:8 ?@>F54C@8 70:C?V2;V).5459147 5@>?5=5<, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )5@>?5=5< ( ) 10<:3, !100, 48A:81D;0:>=8A:8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ;V:0@AL:8E 70A>1V2 $;0:>= - 100 HBC: :0@B>==8E 48A:V2.5559140 V=:><VF8=, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )V=:><VF8= () 15<:3, !100, 48A:81D;0:>=8A:8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ;V:0@AL:8E 70A>1V2 $;0:>= - 100 HBC: :0@B>==8E 48A:V2.5645347 ;0@8B@><VF8=>2V 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro );0@8B@><VF8=>< ( ) 15<:3, !100, 48A:81D;0:>=8A:8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ;V:0@AL:8E 70A>1V2 $;0:>= - 100 HBC: :0@B>==8E 48A:V2.5759139 52>D;>:A0F8=, 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )52>D;>:A0F8= ($) 5<:3, !100, 48A:82 D;0:>=8A:8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ;V:0@AL:8E 70A>1V2 $;0:>= - 100 HBC: :0@B>==8E 48A:V2.5837435 8A: IVD (4V03=>AB8:0 in vitro ) 4;O 28?@>1C20==O =0 A?@89=OB;82VABL 4> 078B@><VF8=C78B@><VF8= (") 15<:3, !100 , 48A:82D;0:>=8A:8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ;V:0@AL:8E 70A>1V2 $;0:>= - 100 HBC: :0@B>==8E 48A:V25945899 <>:A8F8;V=>2V 48A:8 4;O B5ABC20==O =0 GCB;82VABL IVD (4V03=>AB8:0 in vitro )<>:A8F8;V=/:;02C;0=>20 :8A;>B0 (<>:A8:;02)  20/10<:3,!1001D;0:>=8A:8 4;O 287=0G5==O GCB;82>ABV <V:@>>@30=V7<V2 4> ;V:0@AL:8E 70A>1V2 $;0:>= - 100 HBC: :0@B>==8E 48A:V2 # @07V 2:070==O 2 E0@0:B5@8AB8:0E B>@3>2>W <0@:8, 28@07 @>7C<VB8 O:  01> 5:2V20;5=B .  @07V =040==O B>20@C, O:89 =5 2V4?>2V40T 28<>30<, 707=0G5=8< 2 B5E=VG=8E 28<>30E 70:C?V2;V >1>2 O7:>2> =040B8 2 A:;04V ?@>?>78FVW ?>@V2=O;L=C E0@0:B5@8AB8:C 70?@>?>=>20=>3> B>20@C. 0?@>?>=>20=89 5:2V20;5=B <0T 1CB8 70 B5E=VG=8<8 B0 O:VA=8<8 E0@0:B5@8AB8:0<8 @V2=>FV==8<8, 01> ?>:@0I5=8<8, =V6 287=0G5=V 0<>2=8:>< C 40=V9 B5=45@=V9 4>:C<5=B0FVW.  $&02JL*,,.`b \\VXZ\^`̸̸#hiB*OJQJ^JnHphtHhiOJPJQJ^JnHtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtH.hiCJKHOJPJQJ^J_H9aJnHtH6hiCJKHOJPJQJ^J_H9aJmHnHsHtH4.b ^UUUUUUUU $$Ifa$kd3$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti XZ`LA $7$8$H$Ifkd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$Z\\L N \           " 8 : n p     . 0 2 4 > @ x z |          6 8       ,hiCJaJnH"tH".hiCJKHOJPJQJ^J_H9aJnHtH&hiCJOJPJQJ^JaJnHtHhiOJQJ^JI\N     d$If $$Ifa$   " : p   0 4 ^UUUUUUUU $$Ifa$kd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti 4 @ z |     8 Lkd^$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$8    XZ`Lkd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$,.VXZ^`NPTVbdVX$&"$Z\|~JLtvx|~"$z|.hiCJKHOJPJQJ^J_H9aJnHtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtHhiMPVdXLkd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$X&Lkd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$$\~v d$If $$Ifa$vx~$|^UUUUUUU $$Ifa$kdB$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti|*,$&(,.dfFHJLXZ24^`   " $ Z \        !!X".hiCJKHOJPJQJ^J_H9aJnHtHhiCJaJnH"tH"hi&hiCJOJPJQJ^JaJnHtHM,&(.fHULLLLL $$Ifa$kd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$IfHLZ4`Lkd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$`  Lkdm$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$$ \    !" d$If $$Ifa$ X"Z""""""""""".#0#######Z$\$$(%*%R%T%V%Z%\%%%%%%%V&X&Z&\&h&j&&$'&'''((("($(\(^(((((($)&)()*)6)8)))********$+&+R+.hiCJKHOJPJQJ^J_H9aJnHtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtHhiM"""""0####^UUUUUUU $$Ifa$kd&$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti#\$T%V%\%%%%X&ULLLLL $$Ifa$kd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$IfX&\&j&&'(($(^((Lkd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$((&)*)8))***LkdQ$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$*&+T+++,,--. d$If $$Ifa$ R+T+++++,,,,,-----.........*/,/b/d////////00T1V1~1111111111$2&2222222d3f334464^4`4b4f4h444444455z5|5hiCJaJnH"tH"hi.hiCJKHOJPJQJ^J_H9aJnHtH&hiCJOJPJQJ^JaJnHtHM....,/d////^UUUUUUU $$Ifa$kd $$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti/011111&22ULLLLL $$Ifa$kd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If222f3`4b4h444Lkd|$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$445|555J6F7H7Lkd5$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$|5~5555H6J677D7F7H7L7N77777777L8N8P8R8^8`899999:::::P:R:::::; ;;;;;R;;;<<<<<<< ==<=>=Z=\===>>> >,>.>>>???.hiCJKHOJPJQJ^J_H9aJnHtHhiCJaJnH"tH"hi&hiCJOJPJQJ^JaJnHtHMH7N7777N8R8`89: d$If $$Ifa$ :::R::: ;;;^UUUUUUU $$Ifa$kd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti;;<<<=>=\==ULLLLL $$Ifa$kd$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If=> >.>>??? @Lkd`$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$??????@ @P@R@@@ A AAAAAAABBBBBBBCCFCHC~CCCCCCCCDDDxEzEEEEEEEEFFLFNFdFfFFFFFFFFdGfGGGGG) *hiCJOJPJQJ^JaJnHtHhi.hiCJKHOJPJQJ^J_H9aJnHtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtHE @R@@ AAAABBLkd $$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$BBCHCCCCCDE d$If $$Ifa$ EEEEFNFFFF^UUUUUUU $$Ifa$kd $$Iflֈ!Y/F&f7FF/ ffRF t+44 lBaytiFfGGGG6HlHHHULLLLL $$Ifa$kd!$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$IfGGGG4H6HjHlHHHHHHI IIIIJJJJJJJJ K K:KQ@QQQRRRRRRRR6S8SfShSSSSSbTdTfTjTlTxTzTTV V2V4V6V:VW@WLWNWX X```,aaaaaaaa*b,bZb\bxbzbbb ccccc cccdd.hiCJKHOJPJQJ^J_H9aJnHtHhiCJaJnH"tH"hi&hiCJOJPJQJ^JaJnHtHM.ZZ[[[(\B\h\\ULLLLL $$Ifa$kd&$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If\ ]$]2]]^^^,_LkdY'$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$,_`___,`0`>``a d$If $$Ifa$aaa,b\bzbbcc c^UUUUUUUU $$Ifa$kd($$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti ccdddddeeULLLLL $$Ifa$kd($$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$Ifdddddddddd eeee e.e0e>e@eBeDeReTebedenepeeeeeeeeeeeeeee f f0f2f`fbfffffffffggngpgggggFhHhbhdhhhh i i i"itiviii j"j.hiCJKHOJPJQJ^J_H9aJnHtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtHOe0e@eDeTedepeeeeeeee f2fbfffffgpgggHhdhh d$If $$Ifa$h i"ivii"jjjkTkkkFlllJmmnnoJpqqRss d$If"jjjjjjkkRkTkkkkkDlFllllllHmJmmmmmnn>nnnoo>pHpJpqqqq>rPsRssssssss&t(t>t^t`tttttttuuuuuuuuu4v6v>v|v~vvv.hiCJKHOJPJQJ^J_H9aJnHtHhiCJaJnH"tH"hi&hiCJOJPJQJ^JaJnHtHMssss(t`tttt^UUUUUUU $$Ifa$kd)$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBaytituuuuu6v~vvULLLLLL $$Ifa$kd=*$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$Ifvvvbwdwfwjwlwwwwwwwxxhxjxlxnxzx|xNyPyRyVyXyyyyyyyyyzJzLzPzRz^z`z2{4{6{:{<{x{z{{{{{{{<|>|@|B|N|P| }"}$}(}*}^}`}}}}}}}}P~R~T~V~b~.hiCJKHOJPJQJ^J_H9aJnHtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtHOvvdwfwlwwwwxLkd*$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$xjxnx|xPyRyXyyyLkd+$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$yyzLzRz`z4{6{<{Lkdh,$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If $$Ifa$<{z{{{{>|B|P|"} d$If $$Ifa$"}$}*}`}}}}R~V~d~^UUUUUUUU $$Ifa$kd!-$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti b~d~468:؁Ʊ챤hhI{OJQJ^J)hi5CJOJPJQJ^JaJnHtH2hi6B*CJOJPJQJ^JaJnHphtHhiCJaJnH"tH"&hiCJOJPJQJ^JaJnHtH d~68:UI<4$a$gdQ $*$`a$gdi $]a$gdikd-$$Iflֈ!Y/F&f7FF/ ffRF t+44 lBayti d$If21h:p+r. A!"#S$% $$If!vh#v8#v#v0 #v#vR#v:V l  t<+,5755/ 55R599/  /  / / / / / / /  / Bap<yti5$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/  /  / / / / / / /  / Bayti5$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/  /  / / / / / / /  / Bayti5$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/  /  / / / / / / /  / BaytiQ$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ / / / / /  / / /  / / / Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ BBayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ BBayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ BBayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ BBayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti$$If!vh#v8#v#v0 #v#vR#v:V l t+,5755/ 55R599/ Bayti""x666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@66666$OJPJQJ^J_HmH"nH"sH"tH"F`F ^F 28G09=89CJ_HaJmH"sH"tH hh (4& 03>;>2>: 1$$@&'5B*CJOJPJQJ\^JaJph.thh (4& 03>;>2>: 2$$@&'5B*CJOJPJQJ\^JaJph[`` (4& 03>;>2>: 3$$@&5B*OJPJQJ\^Jph[ff (4& 03>;>2>: 4$$@&%56B*OJPJQJ\]^Jph[ZZ (4& 03>;>2>: 5$$@&B*OJPJQJ^JphMx`` (4& 03>;>2>: 6$$@&6B*OJPJQJ]^JphMx`` (4& 03>;>2>: 7$$@&6B*OJPJQJ]^Jph@@@bb (4& 03>;>2>: 8$$@&!B*CJOJPJQJ^JaJph@@@h h (4& 03>;>2>: 9 $$@&'6B*CJOJPJQJ]^JaJph@@@RA R (@8DB 0170FC 70 70<>2GC20==O<Zi@Z 028G09=0 B01;8FO4 l4a 2k 2 0 5<0T A?8A:C R"R =0 0720 >1'T:B06B*CJ]aJphDTj`/` (4&03>;>2>: 2 =0:'5B*CJOJPJQJ\^JaJph[X/X (4&03>;>2>: 3 =0:5B*OJPJQJ\^Jph[^/!^ (4&03>;>2>: 4 =0:%56B*OJPJQJ\]^Jph[R/1R (4&03>;>2>: 5 =0:B*OJPJQJ^JphMxX/AX (4&03>;>2>: 6 =0:6B*OJPJQJ]^JphMxX/QX (4&03>;>2>: 7 =0:6B*OJPJQJ]^Jph@@@Z/aZ (4&03>;>2>: 8 =0:!B*CJOJPJQJ^JaJph@@@`/q` (4&03>;>2>: 9 =0:'6B*CJOJPJQJ]^JaJph@@@>> A0 "5:AB 28=>A:8CJaJD/D A0"5:AB 28=>A:8 =0:CJaJ4& 4 A0 =0: 28=>A:8H*P+P T0"5:AB :V=F52>W 28=>A:8CJaJV/V T0"5:AB :V=F52>W 28=>A:8 =0:CJaJF* F T0=0: :V=F52>W 28=>A:8H*pp  !VB:0 B01;8FV7:V0<< 9  170F A?8A:C ^m$R^R n028G09=89 (251) CJOJPJQJ^JaJX/X i msonormal!dd[$\$CJOJPJQJ^JaJtH"PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭Vb}AaX 5Хз?{FErъa?G~c M\ k5Dn",9yI'-F_5ʍRZ.r0ҡ^-eFQ,% sfVsbuZkP/˹zlנx0K+jSHM'|Xh'3DC_j>h>M((EĞqu!k' B!r[WWڧh #CZ1.bnH1Dw@o@N^:~oO?y2Vem80??廷OJ iař)Nx_S :&M",|c,w$!"F#5CCzg(rض5ڷB>ġnYmhq 3GqL=\sPly1B%.[4(% pƎ=$IJ6r&X_zWEi6Xє m2v[~Uul$ DۘZfFE.mQ[H.1S5zX.N im:l$dҹ3u6(-&@"oI|;D݃Plp2I) d1#J5c]4W=iNfQqa\u2Õdu胟s>%o }#ׄA%>qz8 R:i31a+DC8JI & c#=ԭtm^rϫͤ $\1*K/UuJ@ɞ1MbA<TF҇`4 Ka`q]jPKWbD@N=)?%zW;2=ȘV@=ӫ%vO[$pIhO",4I)C8M*N)} jdR;*QjVªn!e9#if5*j5ô bE`5514'{6NsLV 0xj?G=CA0eY4rdԮYKS3vKks:P٨Ԗ֟۬ɣ}J] 9{4mhPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ttheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] () FN L#' -?JO4VX[jjvX,|X"R+|5?GP.Zd"jvb~JLMNOPQSVZ^adgilptx'4(6(/1>tEFRJKNO`R4VWTZ_b`q2r vvL}@" 4 8 XvH`"#X&(*./24H7:;= @BEFHLR]w~twdi" $ ) + , . K O P R T X Y![!\!a!m!s!t!|!!!!"" "3"5"q"u"""##########$ $ $$$$^%`%a%f%i%s%%%%%%%%%R'T'U'Z'p''''''''''''((a)c)d)i))))))))))))))))****&***>*F*J*M*Q*g*l*++++++.,0,?,I,U,^,_,g,,,,,(-4-X-h-t------A.J.K.S.V.d.........//+>,>.>/>4>L>T>{??????????@@ @ @V@b@c@e@f@k@@@@@@@AA BB6B8BYB`BBBC C"C/CbCuCCC$D+DVD^DxDzDDDDDDDEE FF5FNNN5O7O8O=OgOsOOOOOOOPPPPPPPPPPPPQQ.R0R1R6RERORPRYR]R`R;SES{S}S~SSSSSSSSTTTTTTTUU UUUUV5V7V8V=VLVWVXVeVhVsVwVzVoWqWrWwWWWWWWWXXXXXYYY!Y,Y0Y3Y$Z/ZeZgZhZmZ|ZZZZZZ[[[[[[[[[[[\\\1]3]4]9]H]T]W]b]f]i]Y^i^k^v^^^^^^^^^^^_____!_#_._/_?_C_F___@`I```````````aaaaaab bc cVcXcYc^cmc{c~ccccddddddddddddee+f-f.f3fBfKfLfUfXf[fSg]ggggggggghhiiii)i3i6i@iCiFijjjjjjjjkkkkkk lll"lm mm!m"m'm6mAmBmLmPmSm[n]n^ncnnnnnnnnn.o5oooooooooop pppqqq=q?q@qEqTq\q_qfqjqmq]rhrirsrrrrrrrrrrrrrrrrrrss t>t@tAtFtUt`tctmtqtttzu|u}uuuuuuuuuuvwwww!w0w;w>wIwMwPw{xxxxxxxxxxxxyy"z$z%z*z9zFzIzWzZz]zL{T{U{X{Y{]{_{f{{{{{{{{{{{{{R|V|||} }}} ~~L~Y~[~n~ǂلۄ܄ͅυЅՅ؅ĆІц܆ṡ͇؇* $&o p y >B<=UVp{|$%qr  &'CDNOhi  _`{|23?@89tv<=HI]^jk  / 0 \ ] &!*!l!m!!!!!!!!!""""2"3"Q"R"""h#k###########a$b$+%.%7%8%s%u%%%%%8&9&''$'%'9':'Q'R'_'`'''''H(I(()*)H)I)`)a)n)o))))) **++++++,, , ,+,,,0,1,u/v///0011 2 2|2}2-3.344444444555556h677 7"7#7;7<7V7W7]7^7h7i7m7n788+8,8s8t8888899%9&9?9@999=:>:i:j:::::::::L;M;Q;R;;;;;+<,< = ====={=|=====U>V>t>u>>>p?r?t?u?z?{???@ @ @@@@@@@@AAAAAAAAAABB B BBBB B3B4B8B9BBBACBCaCbCCCCCDDDDDD+D,D;DE@EBECEiEjEgFhFjFkFpFqF}F~FFFFF+G,GDGEGGGGGGGGGH H#H$H/H0H]H^HdHeH$J%JJJJJJJJJ=K>KDKEKaKbKKKKKKKLL=L>L[L\L~MMMMMMMMMMMMMMNN(N)N@NANoNpNwNxNOOOO7O8OPOQOfOgOsOtOOOOOPPPPPPPPPPPQQQ Q QQQQQRRRR8R9RaRbRjRkR0S2S4S5SPSQSiSjSSSSSSSTTTTTTTTTTTTUUUUU UmUnUUUUU V V#V$V?V@V{V|VVVVVNWPWRWSWqWrWWWWWWWWWWWWW4X5XXXXXXXXXYY4Y5Y7Y8Y>Y?YYYZZZZ:Z;ZSZTZoZpZZZZZZZ[[[[[[[[[[[[\\ \ \j\k\\\\\]]] ];]<]j]k]s]t]]]N^P^R^S^j^k^^^^^^^P_Q_Y_Z___5`7`9`:`T`U`m`n```````aaaaaaaaaaaa"b#b+b,bbbc c c c'c(c9c:cHcIc`caccccccczd|d~ddddddddddeeeefeeeeeffff5f6f\f]f_f`fffgfff?gAgCgDg^g_gvgwgggggggggLhMhhhhhhhiiii]i^ifigiii@jBjDjEjbjcj{j|jjjjjjj.k/kkkkkkkkkkk#l$l,l-lllllllll mm)m*mTmUmWmXm^m_mmm:nn?n]n^nunvnnnnnnnnnooooooooooooppppppxpypppppqqqq/q0qGqHqnqoqwqxqqqRrTrVrWrsrtrrrrrrr s s sssssssstt,t-tHtItutvt~ttttYu[u]u^u|u}uuuuuuuuuuuuuLvMvvvvvvvvv w w#w$wgwhwpwqwwwKxMxOxPxmxnxxxxxxxxxxxTyUyyyyyyyzzzz,z-z^z_zgzhzzzA{C{E{F{K{L{T{U{^{_{f{g{o{p{w{x{{{{{{{{{{{{{{{{{{{{{{{{{| | |!|6|7|?|@|e|f||||||||| } }7}8}]}^}h}i}}}}}}}~~9~:~Z~[~~~~~~~~~%&NO|}@AZ[Áā҂ӂ*+34փ׃ ˄̄ ׅ؅qsuvÆĆІцhjlm ru&*33 n z '* n z '*v58h.^.`sH")^`o(.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.58WW8Num3m 5:9)+;G4o!b!K #;>HM9RZ]s^$k^saae+qwvgXx3IM I{-tZ+r9yh>n6?b\ifpcQq(*@''''p "(7E( LXvUnknownG.[x Times New Roman5Symbol3. .[x Arial;(SimSun[SO5Mangal7..{$ CalibriC.,.{$ Calibri LightA$BCambria Math"qsg_C' W)2FkW)2Fk!S20 3Q@P $Pb!!xxۋ> Olga0BO  Oh+'0T    (4<DLOlgaNormal12Microsoft Office Word@@J@N۲@'&BW)2 ՜.+,0 hp|  kF     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUWXYZ[\]_`abcdejknRoot Entry Fpb:&BmData .1Table njWordDocument 4SummaryInformation(VDocumentSummaryInformation8^MsoDataStoreP:&B`;:&BF4QEH5XECUOMIF==2P:&B`;:&BItem  PropertiesUCompObj r   F Microsoft Word 97-2003 MSWordDocWord.Document.89q